PortfoliosLab logoPortfoliosLab logo
ISIN
US98945L1052
CUSIP
98945L105
IPO Date
Feb 8, 2018

Highlights

Market Cap
$4.80M
Enterprise Value
$304.09M
EPS (TTM)
-CN¥33.26
Total Revenue (TTM)
CN¥1.92B
Gross Profit (TTM)
CN¥743.06M
EBITDA (TTM)
-CN¥179.07M
Year Range
$2.44 - $61.85
Target Price
$12.00
ROA (TTM)
-7.63%
ROE (TTM)
-20.94%

Share Price Chart


Loading charts...

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Zepp Health Corporation

Performance

ZEPP Performance Chart

Zepp Health Corporation (ZEPP) is down 82.0% since the beginning of the year. At $5 per share, ZEPP is trading 92.2% below its 52-week high of $62. Investors who bought $1,000 worth of ZEPP shares 5 years ago would now be looking at an investment worth $113.


Loading charts...

S&P 500 Index

Returns By Period

Zepp Health Corporation (ZEPP) has returned -82.03% so far this year and 99.18% over the past 12 months.


Zepp Health Corporation

1D
0.21%
1M
-43.85%
YTD
-82.03%
6M
-83.31%
1Y
99.18%
3Y*
2.61%
5Y*
-35.33%
10Y*

Benchmark (S&P 500 Index)

1D
-0.37%
1M
-0.01%
YTD
9.16%
6M
8.64%
1Y
25.22%
3Y*
19.78%
5Y*
11.99%
10Y*
13.88%
*Multi-year figures are annualized to reflect compound growth (CAGR)

ZEPP Monthly Returns History

Based on dividend-adjusted daily data since Feb 8, 2018, ZEPP's average daily return is +0.03%, while the average monthly return is +3.45%. At this rate, an investment would double in approximately 1.7 years.

Historically, 38% of months were positive and 62% were negative. The best month was Jul 2025 with a return of +406.0%, while the worst month was May 2026 at -53.3%. The longest winning streak lasted 4 consecutive months, and the longest losing streak was 9 months.

On a daily basis, ZEPP closed higher 45% of trading days. The best single day was Jul 11, 2025 with a return of +69.5%, while the worst single day was Jun 9, 2026 at -28.6%.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
2026-33.11%6.99%-38.02%46.19%-53.29%-40.69%-82.03%
20257.69%-4.64%10.86%-12.16%-2.50%4.93%406.02%234.32%1.73%-11.80%-33.26%-0.04%936.15%
2024-14.08%-7.38%-9.73%-17.65%-9.38%-21.18%-4.80%31.30%45.00%-26.21%-2.18%-17.20%-54.23%
202342.76%-18.36%-22.49%11.45%-19.18%-3.39%14.04%-16.92%6.48%-10.43%33.98%2.90%-2.07%
2022-1.39%-26.91%-18.20%-15.97%-15.70%-9.31%-5.95%9.77%-28.27%-10.22%-2.44%20.83%-70.31%
202115.70%20.57%-34.85%-4.64%-2.73%17.52%-5.11%-2.33%-26.19%2.24%-17.30%-25.63%-57.38%

Benchmark Metrics

Zepp Health Corporation has an annualized alpha of -6.55%, beta of 0.97, and R2 of 0.05 versus S&P 500 Index. Calculated based on daily prices since February 08, 2018.

  • This stock participated in 184.59% of S&P 500 Index downside but only 58.91% of its upside - more exposed to losses than it benefited from rallies.
  • R2 of 0.05 means this stock moves largely independently of S&P 500 Index - capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.

Alpha
-6.55%
Beta
0.97
0.05
Upside Capture
58.91%
Downside Capture
184.59%

Return for Risk

Risk / Return Rank

ZEPP ranks 69 for risk / return — better than 69% of stocks on our site. You're getting solid returns for the risk taken. A good sign, especially for investors who want growth without excessive volatility.


ZEPP Risk / Return Rank: 6969
Overall Rank
ZEPP Sharpe Ratio Rank: 6262
Sharpe Ratio Rank
ZEPP Sortino Ratio Rank: 8080
Sortino Ratio Rank
ZEPP Omega Ratio Rank: 7777
Omega Ratio Rank
ZEPP Calmar Ratio Rank: 6464
Calmar Ratio Rank
ZEPP Martin Ratio Rank: 6060
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

Return / Risk — by metrics

The table below present risk-adjusted performance metrics for Zepp Health Corporation (ZEPP) and compare them to S&P 500 Index.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


ZEPPBenchmarkDifference
Sharpe ratioReturn per unit of total volatility

-1.42

Sortino ratioReturn per unit of downside risk

-0.53

Omega ratioGain probability vs. loss probability

1.27

1.37

-0.10

Calmar ratioReturn relative to maximum drawdown

1.07

2.78

-1.72

Martin ratioReturn relative to average drawdown

1.78

12.44

-10.66

Dividends

Dividend History

Zepp Health Corporation provided a 0.00% dividend yield over the last twelve months, with an annual payout of $0.00 per share.


0.00%1.00%2.00%3.00%4.00%5.00%6.00%7.00%$0.00$0.10$0.20$0.30$0.402022202320242025
Dividends
Dividend Yield
PeriodTTM2025202420232022
Dividend$0.00$0.00$0.00$0.00$0.40

Dividend yield

0.00%0.00%0.00%0.00%6.90%

Monthly Dividends

The table displays the monthly dividend distributions for Zepp Health Corporation. The dividends shown in the table have been adjusted to account for any splits that may have occurred.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
2026$0.00$0.00$0.00$0.00$0.00$0.00$0.00
2025$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00
2024$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00
2023$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00
2022$0.40$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.40

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


Loading charts...

Worst Drawdowns

The table below displays the maximum drawdowns of the Zepp Health Corporation. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Zepp Health Corporation was 97.30%, occurring on Aug 5, 2024. The portfolio has not yet recovered.

The current Zepp Health Corporation drawdown is 93.66%.


Related event

Drawdown

Fall

Recovery

Underwater

2024 bear market2024
-97.30%Aug 2024
3y 5mo
5y 4moFeb 2021 - now
2019 bear market2019
-61.54%May 2019
2mo 28d1y 8mo
1y 11moMar 2019 - Feb 2021
2018 bear market2018
-35.78%Jun 2018
15d7mo 23d
8mo 8dJun 2018 - Feb 2019
2018 bear market2018
-27.42%Apr 2018
2mo 15d1mo 18d
4mo 3dFeb 2018 - Jun 2018
2019 pullback2019
-1.49%Feb 2019
0s2d
2dFeb 2019 - Mar 2019

Drawdown Indicators


ZEPPBenchmarkDifference

Max Drawdown

Largest peak-to-trough decline

-97.30%

-56.78%

-40.52%

Max Drawdown (1Y)

Largest decline over 1 year

-93.49%

-9.10%

-84.39%

Max Drawdown (3Y)

Largest decline over 3 years

-93.49%

-18.90%

-74.59%

Max Drawdown (5Y)

Largest decline over 5 years

-95.72%

-25.43%

-70.29%

Max Drawdown (10Y)

Largest decline over 10 years

-33.92%

Current Drawdown

Current decline from peak

-93.66%

-1.80%

-91.86%

Average Drawdown

Average peak-to-trough decline

-62.83%

-10.71%

-52.12%

Ulcer Index

Depth and duration of drawdowns from previous peaks

55.96%

2.03%

+53.93%

Volatility

Volatility Chart

The chart below shows the rolling one-month volatility.


Loading charts...

Financials

Financial Performance

The chart below illustrates the trends in the financial health of Zepp Health Corporation over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.


Annual
Quarterly

0.0

Valuation

The Valuation section provides an overview of how Zepp Health Corporation is priced in the market compared to other companies in the Scientific & Technical Instruments industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.


PS Ratio

This chart shows the Price-to-Sales (P/S) ratio for ZEPP relative to other companies in the Scientific & Technical Instruments industry. Currently, ZEPP has a P/S ratio of 0.1. This P/S ratio is low compared to the industry average. It may indicate that the stock is undervalued relative to its revenue, or that the market expects slower growth or lower margins.

PB Ratio

The chart illustrates the Price-to-Book (P/B) ratio for ZEPP in comparison with other companies in the Scientific & Technical Instruments industry. Currently, ZEPP has a P/B value of 0.0. This P/B ratio is low compared to industry peers. It might indicate the stock is undervalued or that the company’s assets are not expected to generate strong returns.

Income Statement



TTM
Revenue

Total Revenue

Cost Of Revenue

Gross Profit

Operating Expenses

Selling, General & Admin Expenses

R&D Expenses

Depreciation And Amortization

Total Operating Expenses

Income

Income Before Tax

Operating Income

EBITDA

EBIT

Earnings From Continuing Operations

Net Income

Income Tax Expense

Other Non-Operating Income (Expenses)

Extraordinary Items

Discontinued Operations

Effect Of Accounting Charges

Non Recurring

Minority Interest

Other Items

Interest Income

Interest Expense

Net Interest Income

Values in undefined except per share items
Portfolio Analyzer

Build a portfolio with ZEPP

Add Zepp Health Corporation to a portfolio and analyze allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Analyzer with ZEPP